HORIZON-HLTH-2023-DISEASE-03-07
HORIZON-HLTH-2023-DISEASE-03-07
Programme: Horizon Europe
9 projects · €64,355,618 total EU contribution (project-level) · 96 participating organizations · 25 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€64,355,618
Countries active
Participant organizations by country (headquarters in CORDIS).
- Spain (13)
- Germany (11)
- France (11)
- Italy (9)
- Netherlands (7)
- FI (6)
- NO (6)
- AT (4)
- CZ (4)
- CH (3)
- DK (3)
- AU (2)
- BE (2)
- HU (2)
- LU (2)
- US (2)
- CY (1)
- EE (1)
- EL (1)
- IE (1)
- IL (1)
- SE (1)
- SI (1)
- SK (1)
- UK (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- KI3 projects · SE
- UNIVERSITY OF TARTU3 projects · EE
- HELLENIC INSTITUTE FOR THE STUDY OF SEPSIS2 projects · EL
- VHIR2 projects · ES
- HMGU2 projects · DE
- INSERM2 projects · FR
- UCPH2 projects · DK
- THE CYPRUS FOUNDATION FOR MUSCULAR DYSTROPHY RESEARCH CYRUS INSTIT OF NEURO & GENETICS2 projects · CY
- OUS2 projects · NO
- E.M.S.P.2 projects · BE
- UNIVERSITAIR MEDISCH CENTRUM GRONINGEN1 projects · NL
- Leiden University Medical Center1 projects · NL
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
COMORBIDITY MECHANISMS UTILIZED IN HEALTHCARE COMMUTE · 101136957 | HORIZON | €7,280,986 | €550,000 | Details |
ENTEROVIRUS-LINKED TYPE 1 DIABETES EXPOSED -MECHANISMS AND PREVENTION ENT1DEP · 101137457 | HORIZON | €7,144,790 | €121,875 | Details |
Unraveling the dark matter of infectious diseases, environmental and genetic factors tipping the balance towards NCDs ID-DarkMatter-NCD · 101136582 | HORIZON | €7,185,361 | €851,250 | Details |
Targeting Epstein-Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis EBV-MS · 101136991 | HORIZON | €7,549,863 | €1,578,834 | Details |
Biomarkers established to stratify sepsis long-term adverse effects to improve patients’ health and quality of life BEATsep · 101137484 | HORIZON | €6,912,872 | €993,819 | Details |
Long-term alterations of host-microbiome interactions and cardiovascular and respiratory diseases progression after pneumonia Homi-lung · 101137148 | HORIZON | €6,999,983 | €914,013 | Details |
The role of an Epstein-Barr virus infection in the pathogenesis of multiple sclerosis BEHIND-MS · 101137235 | HORIZON | €7,550,709 | €248,720 | Details |
Preventing non-communicable diseases caused by the post-acute phase of cOvid-19 INfecTion POINT · 101137196 | HORIZON | €6,676,490 | €495,250 | Details |
Causative Link between respirAtory syncytial viRus and chronic lung diseases: Identifying Targets for therapY CLARITY · 101137201 | HORIZON | €7,054,563 | €0 | Details |